🌍·3h agoIndustry
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
Publisher
R
Relmada Therapeutics
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Relmada Therapeutics
- Region
- 最新
- Scope
- Industry
- Published
- June 11, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on relmada.com
Leave the platform to read the original full article on the publisher site.
Source: Relmada Therapeutics
Scope: Industry
Related coverage
More related coverage
WuXi Biologics·5h ago
WuXi Biologics Included in S&P Global Sustainability Yearbook (China Edition) for Fourth Consecutive Year
Cellectis·7h ago
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress
Fierce Biotech (Latest)·17h ago
Virtual Data. Real Rigor. Setting the VCG Standard
eXoZymes·3d ago